Skip to main content

NEJM Group
Follow Us
- Facebook
- Twitter
- Instagram
- YouTube
- LinkedIn

Prepare to become a physician, build your knowledge, lead a health care organization, and advance your career with NEJM Group information and services.

NEJM Evidence
NEW! A digital journal for innovative original research and fresh, bold ideas in clinical trial design and clinical decision-making.
NEJM Catalyst
NEW! Peer-reviewed journal featuring in-depth articles to accelerate the transformation of health care delivery.
NEJM Journal Watch
Concise summaries and expert physician commentary that busy clinicians need to enhance patient care.
NEJM Knowledge+
The most effective and engaging way for clinicians to learn, improve their practice, and prepare for board exams.
NEJM Resident 360
Information, resources, and support needed to approach rotations - and life as a resident.
NEJM Healer
The most advanced way to teach, practice, and assess clinical reasoning skills.
NEJM 医学前沿
The authorized source of trusted medical research and education for the Chinese-language medical community.
NEJM Career Center
Valuable tools for building a rewarding career in health care.
NEJM Library Hub
Information and tools for librarians about site license offerings.
The New England Journal of Medicine
The most trusted, influential source of new medical knowledge and clinical best practices in the world.

Sign In
Create Account
Subscribe

Stay connected to what's important in medical research and clinical practice

Subscribe to the most trusted
and influential source of
medical knowledge

Devices

Subscribe

Already a subscriber? Renew or Sign in

Device Global Header

Subscribe
or Renew

Search site Keyword

Search
Home
Specialties
Specialties
Selected specialties
View all specialties
Topics
Topics
Selected Topics
View all topics
Multimedia
Multimedia
Selected Multimedia
View all multimedia
Current Issue
Current Issue
Current Issue
- Current Issue
- September 1, 2022 Vol. 387 No. 9
Recent Issues
Browse full issue index
Recently Published Articles
Browse recently published
Learning/CME
Learning/CME
View all learning/CME
Other NEJM Group Learning
Author Center
Covid-19

Subscribe
or Renew

Keyword

Advanced Search

Search Results

ArticlesFigures/Multimedia

FilterHide Filters

Showing 1-20 of 213 results

By Specialty

Infectious Disease66
Hematology/Oncology50
Cardiology34
Pediatrics32
Pulmonary/Critical Care28
Surgery22
Neurology/Neurosurgery21
Clinical Medicine20
Genetics18
Gastroenterology16
Emergency Medicine16
Allergy/Immunology16
Nephrology14
Endocrinology13
Obstetrics/Gynecology11
Dermatology10
Rheumatology8
Medical Practice, Training, and Education6
Geriatrics/Aging6
Urology/Prostate Disease6
Health Policy5
Psychiatry4
Orthopedics4
Public Health4
Radiology4
Diversity, Equity, and Inclusion2
Otolaryngology1
Ophthalmology1

By Media Type

Figure200
Table12
Videos in Clinical Medicine1
Video1

By Date

Past 6 months
Past year
Past 5 Years
Past 10 Years

FromTo

Original ArticleVOL. 387 No. 9, Sep 01, 2022
Bedaquiline–Pretomanid–Linezolid Regimens for Drug-Resistant Tuberculosis
Bedaquiline–Pretomanid–Linezolid Regimens for Drug-Resistant Tuberculosis
F. Conradie and Others
N Engl J Med 2022; 387:810-823
Download PDF Sign In or Create Account to save this article
FREE
Original ArticleVOL. 387 No. 9, Sep 01, 2022
Fractional Flow Reserve or Intravascular Ultrasonography to Guide PCI
Fractional Flow Reserve or Intravascular Ultrasonography to Guide PCI
B.-K. Koo and Others
N Engl J Med 2022; 387:779-789
Download PDF Sign In or Create Account to save this article
CME
Original ArticleVOL. 387 No. 8, Aug 25, 2022
Ublituximab versus Teriflunomide in Relapsing Multiple Sclerosis
Ublituximab versus Teriflunomide in Relapsing Multiple Sclerosis
L. Steinman and Others
N Engl J Med 2022; 387:704-714
Download PDF Sign In or Create Account to save this article
Original ArticleVOL. 387 No. 8, Aug 25, 2022
Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022
Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022
J.P. Thornhill and Others
N Engl J Med 2022; 387:679-691
Download PDF Sign In or Create Account to save this article
FREE
Original ArticleVOL. 387 No. 8, Aug 25, 2022
Aflibercept Monotherapy or Bevacizumab First for Diabetic Macular Edema
Aflibercept Monotherapy or Bevacizumab First for Diabetic Macular Edema
C.D. Jhaveri and Others
N Engl J Med 2022; 387:692-703
Download PDF Sign In or Create Account to save this article
Original ArticleVOL. 387 No. 8, Aug 25, 2022
Olokizumab versus Placebo or Adalimumab in Rheumatoid Arthritis
Olokizumab versus Placebo or Adalimumab in Rheumatoid Arthritis
J.S. Smolen and Others
N Engl J Med 2022; 387:715-726
Download PDF Sign In or Create Account to save this article
CME
Original ArticleVOL. 387 No. 7, Aug 18, 2022
Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19
Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19
C.T. Bramante and Others
N Engl J Med 2022; 387:599-610
Download PDF Sign In or Create Account to save this article
FREE
Original ArticleVOL. 387 No. 7, Aug 18, 2022
Lower versus Higher Glycemic Criteria for Diagnosis of Gestational Diabetes
Lower versus Higher Glycemic Criteria for Diagnosis of Gestational Diabetes
C.A. Crowther and Others
N Engl J Med 2022; 387:587-598
Download PDF Sign In or Create Account to save this article
CME
Original ArticleVOL. 387 No. 6, Aug 11, 2022
Teclistamab in Relapsed or Refractory Multiple Myeloma
Teclistamab in Relapsed or Refractory Multiple Myeloma
P. Moreau and Others
N Engl J Med 2022; 387:495-505
Download PDF Sign In or Create Account to save this article
Original ArticleVOL. 387 No. 6, Aug 11, 2022
Fazirsiran for Liver Disease Associated with Alpha₁-Antitrypsin Deficiency
Fazirsiran for Liver Disease Associated with Alpha₁-Antitrypsin Deficiency
P. Strnad and Others
N Engl J Med 2022; 387:514-524
Download PDF Sign In or Create Account to save this article
Original ArticleVOL. 387 No. 6, Aug 11, 2022
Removal of Small, Asymptomatic Kidney Stones and Incidence of Relapse
Removal of Small, Asymptomatic Kidney Stones and Incidence of Relapse
M.D. Sorensen and Others
N Engl J Med 2022; 387:506-513
Download PDF Sign In or Create Account to save this article
CME
Original ArticleVOL. 387 No. 5, Aug 04, 2022
Low-Dose Subcutaneous or Intravenous Monoclonal Antibody to Prevent Malaria
Low-Dose Subcutaneous or Intravenous Monoclonal Antibody to Prevent Malaria
R.L. Wu and Others
N Engl J Med 2022; 387:397-407
Download PDF Sign In or Create Account to save this article
FREE
Original ArticleVOL. 387 No. 5, Aug 04, 2022
Once-Weekly Dulaglutide for the Treatment of Youths with Type 2 Diabetes
Once-Weekly Dulaglutide for the Treatment of Youths with Type 2 Diabetes
S.A. Arslanian and Others
N Engl J Med 2022; 387:433-443
Download PDF Sign In or Create Account to save this article
CME
Original ArticleVOL. 387 No. 5, Aug 04, 2022
Trial of Prasinezumab in Early-Stage Parkinson’s Disease
Trial of Prasinezumab in Early-Stage Parkinson’s Disease
G. Pagano and Others
N Engl J Med 2022; 387:421-432
Download PDF Sign In or Create Account to save this article
Original ArticleVOL. 387 No. 5, Aug 04, 2022
Trial of Cinpanemab in Early Parkinson’s Disease
Trial of Cinpanemab in Early Parkinson’s Disease
A.E. Lang and Others
N Engl J Med 2022; 387:408-420
Download PDF Sign In or Create Account to save this article
Original ArticleVOL. 387 No. 4, Jul 28, 2022
Trial of Anti-BDCA2 Antibody Litifilimab for Cutaneous Lupus Erythematosus
Trial of Anti-BDCA2 Antibody Litifilimab for Cutaneous Lupus Erythematosus
V.P. Werth and Others
N Engl J Med 2022; 387:321-331
Download PDF Sign In or Create Account to save this article
Original ArticleVOL. 387 No. 4, Jul 28, 2022
Overall Survival with Brentuximab Vedotin in Stage III or IV Hodgkin’s Lymphoma
Overall Survival with Brentuximab Vedotin in Stage III or IV Hodgkin’s Lymphoma
S.M. Ansell and Others
N Engl J Med 2022; 387:310-320
Download PDF Sign In or Create Account to save this article
Original ArticleVOL. 387 No. 4, Jul 28, 2022
Supplemental Vitamin D and Incident Fractures in Midlife and Older Adults
Supplemental Vitamin D and Incident Fractures in Midlife and Older Adults
M.S. LeBoff and Others
N Engl J Med 2022; 387:299-309
Download PDF Sign In or Create Account to save this article
CME
Original ArticleVOL. 387 No. 3, Jul 21, 2022
Tirzepatide Once Weekly for the Treatment of Obesity
Tirzepatide Once Weekly for the Treatment of Obesity
A.M. Jastreboff and Others
N Engl J Med 2022; 387:205-216
Download PDF Sign In or Create Account to save this article
CME
Original ArticleVOL. 387 No. 3, Jul 21, 2022
Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer
Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer
J. Cortes and Others
N Engl J Med 2022; 387:217-226
Download PDF Sign In or Create Account to save this article
CME

Page 1

1 2 3 4 5...11

高影响力医学文献及研究成果

站在医学前沿，与权威医学信息相伴

Article Categories

Research
Reviews
Clinical Cases
Perspective
Commentary
Other
Browse all Articles
Current Issue
Issue Index

Resources

Authors & Reviewers
Submit a Manuscript
Subscribers
Institutions
Media
Advertisers
Agents
Permissions
Reprints
NEJM CareerCenter

About Us

About NEJM
Products & Services
Editors & Publishers
Advertising Policies
Contact Us
Accessibility
FAQs
Help
Site Feedback

Subscriptions

Subscribe
Renew
Activate Subscription
Create Account
Manage Account
Pay Bill
Special Content

Stay Connected

Email Alerts
Create Account
Apps
NEJM CareerCenter
Podcasts
RSS Feed
Remote Access

Follow Us

Facebook
Twitter
Instagram
YouTube
LinkedIn

JOURNALS

The New England Journal of Medicine
NEJM Catalyst Innovations in Care Delivery
NEJM Evidence

Copyright © 2022 Massachusetts Medical Society.
All rights reserved.
Electronic ISSN 1533-4406.
Print ISSN 0028-4793.
The content of this site is intended for health care professionals.
Copyright
Terms
Privacy Policy